Abstract
The apparent rise of bone disorders demands advanced treatment protocols involving tissue engineering. Here, we describe self-assembling tetrapeptide scaffolds for the growth and osteogenic differentiation of human mesenchymal stem cells (hMSCs). The rationally designed peptides are synthetic amphiphilic self-assembling peptides composed of four amino acids that are nontoxic. These tetrapeptides can quickly solidify to nanofibrous hydrogels that resemble the extracellular matrix and provide a three-dimensional (3D) environment for cells with suitable mechanical properties. Furthermore, we can easily tune the stiffness of these peptide hydrogels by just increasing the peptide concentration, thus providing a wide range of peptide hydrogels with different stiffnesses for 3D cell culture applications. Since successful bone regeneration requires both osteogenesis and vascularization, our scaffold was found to be able to promote angiogenesis of human umbilical vein endothelial cells (HUVECs) in vitro. The results presented suggest that ultrashort peptide hydrogels are promising candidates for applications in bone tissue engineering.
Introduction
Bone is a solid organ that undergoes calcification and forms the body’s skeletal tissue. Considerable loss of bone density occurs as a result of trauma, disease, infection, and aging. Therefore, bone correction is often needed. This process is mostly done through surgery, implementing metal or ceramic implants and grafts.1 More than 1.5 million bone grafts are fabricated annually.2 There are three primary types of bone grafts used, i.e., autografts, allografts, and xenografts, with all having serious drawbacks. These include running the risk of donor-site morbidity, infection, blood loss, immune rejection, pain, different rates of resorption, and poor performance in some clinical procedures.3−6 To overcome these challenges, tissue defects have been treated through tissue engineering strategies.7 The subject of bone tissue engineering includes the use of cells, biomaterials, and suitable growth factors to create an ideal environment that promotes bone tissue growth and regeneration.8,9
Bone-marrow-derived mesenchymal stem cells (BM-MSCs) have emerged as key players in tissue engineering and regenerative medicine because of their multipotency. They have the ability to readily produce progenitors for many cell types, such as osteocytes, chondrocytes, adipocytes, and myocytes.10 In addition to this, BM-MSCs avoid the ethical questions that arise from the use of embryonic stem cells, are reported to have immune-suppressive effects, and are easy to isolate, culture, and expand.11,12 In the context of bone tissue engineering, BM-MSCs have been reported to have the capability to differentiate into the osteogenic lineage in vitro if cultured with media supplemented with appropriate differentiation cocktail.13
Scaffolds have played an important role in the repair and regeneration of a wide range of tissue types. These structures provide a supportive matrix and an essential environment for cells to spread, migrate, grow, and differentiate into specific lineages.12 Naturally derived materials like tumor-derived basement membrane matrix gel (Matrigel),14−16 collagen,17,18 can enhance cell and tissue function and regeneration. Nonetheless, there are questions about the safety of Matrigel in the possibility to use it for clinical purposes because its components are originated from Engelbreth–Holm–Swarm sarcomas19 and because it is established that Matrigel and the basement membrane matrix promote tumor growth and tumorigenesis in vivo.20,21 On the other hand, collagen, an essential component found in the extracellular matrix (ECM), has been extensively utilized as a supportive compound in tissue engineering scaffolds because it shows no or low inflammatory responses, low antigenicity, and biodegradability.22 However, collagen matrices lack sufficient mechanical strength and degrade quite quickly.23
Bone scaffolds should have the necessary osteoinductive and osteoconductive properties and good mechanical strength to direct neighboring cells to ectopic bone formation in the area of interest.24−26 Several scaffolds have been tested to temporarily fill bone defects, which need an additional surgery for replacement or removal. The design of a nanofibrous scaffold, capable of guiding the osteogenic differentiation of BM-MSCs, is a promising strategy to achieve clinically successful bone grafts.12,27 As autogenous peptides exist naturally within the human body, their nontoxic and biocompatible nature should come as no surprise. Peptides have all of the molecular information required to form well-ordered nanostructures.28 These materials can be designed to have bioactive epitopes to enhance adhesion,29 migration,30 and differentiation31 and other biological functions such as mineralization.32 However, recreating the ECM’s complexity, diversity, and dynamic existence remains an unresolved issue.33 Also, because of their low mechanical properties, the use of hydrogels in bone tissue engineering is limited.34 Nowadays, self-assembling peptides have gained attention in regenerative medicine including bone regeneration. Recently, the HA-Tyr/RGDS-PA/osteo-PA/angio-PA hydrogel was found to successfully promote human adipose-derived mesenchymal stem cell (h-AMSC) adhesion and osteoblastic differentiation and support human umbilical vein endothelial cells (HUVECs) to grow into vascular tubules.33 Another group reported that the E1Y9 (Ac-E-YEYKYEYKY-NH2) amphiphilic peptide can be self-assembled into fibers in the presence of the Ca2+ ion. These peptides are found to stimulate osteoblast cell growth as well as differentiation.35 Furthermore, RATEA16 loading with the vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2) was reported to support cell proliferation, migration, and tube formation of HUVECs as well as osteogenesis of human apical papilla stem cells (SCAPs).36 However, all of these hydrogels were functionalized with bioactive sequences to enhance their ability to stimulate osteogenic differentiation.
RADA16 is one of the most widely used self-assembling peptides for three-dimensional (3D) cell cultures. It was successfully investigated to achieve new bone formation and support osteogenic differentiation.37−40 Due to its acidity, the pH of the self-assembled RADA16 hydrogel needs to be equilibrated to physiological pH prior to cell seeding or in vivo transplantation by immediately adding a large amount of media.41−43 In contrast, under physiological conditions and a specific concentration, our peptides can quickly solidify and provide a 3D environment that supports cell growth, migration, proliferation, and differentiation.44,45 These peptides need a low concentration to quickly form a gel with good mechanical properties. Furthermore, we can easily tune the stiffness of these peptide hydrogels by increasing the peptide concentration, which provides a wide range of hydrogels with different stiffnesses for 3D cell culture applications.
In this study, we used our previously developed hydrogels made from amphiphilic ultrashort peptides44 that self-assemble into nanofibrous scaffolds, which are excellent candidates for use in tissue engineering applications.46,47 The resulting hydrogels are biocompatible and quickly gel to provide a 3D structure similar to that of the extracellular matrix (ECM).48,49 The aim of the current study is to investigate the efficacy of ultrashort peptide hydrogels in supporting the adhesion, spread, proliferation, and osteogenic differentiation of BM-MSCs. The osteogenic differentiation of hMSCs by these hydrogels was evaluated by investigating mineralization, alkaline phosphatase (ALP) production, osteocalcin, and osteogenic gene expression of hMSCs. In addition, the effect of the mechanical stimuli of the matrix was studied by testing the efficiency of the scaffold with two different stiffnesses to support the differentiation of hMSCs toward osteocytes. Given that successful bone regeneration needs both good osteogenesis and vascularization, providing scaffolds that can support both osteogenic and angiogenic properties is much required. In this investigation, the angiogenic properties of tetrapeptide hydrogels were investigated using human umbilical vein endothelial cells (HUVECs). To the best of our knowledge, this is the first report of BM-MSC osteogenic differentiation in these ultrashort tetrapeptides for applications in bone tissue engineering.
Experimental Section
Peptide Synthesis
The peptide sequences Ac-Ile-Val-Phe-Lys-NH2 (IVFK) and Ac-Ile-Val-Cha-Lys-NH2 (IVZK) were synthesized using Fmoc-based solid-phase peptide synthesis (SPPS)44 and purified using liquid chromatography–mass spectroscopy (LC–MS). Detailed description is provided in the Experimental Section, Supporting Information.
Hydrogel Formation and Characterization
The lyophilized peptide powders were dissolved in Milli-Q water by vortexing into a clear solution at room temperature. Then, 10× phosphate-buffered saline (PBS) was added to the aqueous peptide solution at a final volume ratio of peptide solution to 10× PBS of 9:1. The vial inversion test was performed with different peptide concentrations to find the critical gelation concentration (CGC). To study the spatial structure of the peptide solution during the assembly process, two-dimensional (2D) NMR was performed using Bruker Avance III 600 MHz. Furthermore, scanning electron microscopy (SEM) was performed to visualize the morphology of the self-assembled nanofibers. More details are described in the Experimental Section, Supporting Information.
Mechanical Characterization of Hydrogel Stiffness
The oscillatory rheological test was performed to determine the mechanical properties of the peptide hydrogels. The peptide hydrogels were measured on a TA Ares G2 rheometer with an 8 mm parallel-plate geometry and a 1.5 mm gap distance at a temperature of 22 °C. All of the hydrogels were made inside a Sigmacote-coated glass ring with 9 mm inner diameter 19 h prior to measurement. Six replicates with a volume of 150 μL were prepared for each sample. The measurement was performed for 5 min with constant angular frequency and strain at 1 Hz and 0.1%.
Cell Culture of Human Bone Marrow Mesenchymal Stem Cells
Cells were cultured in a medium and supplemented with mesenchymal cell growth supplements. The cells were maintained in either a T75 or a T150 cell culture flask at 37 °C in a humidified incubator with 95% air and 5% CO2. The cells were subcultured when cells reached approximately 80% confluency by trypsin. The culture medium was changed every 2–3 days.
Characterization and Preparation of 3D Culture of Human-Bone-Marrow-Derived Mesenchymal Stem Cells (hBM-MSCs)
The hBM-MSCs were cultured in T75 flasks and incubated in a CO2 incubator maintained at 37 °C with 5% CO2. Culture media were replaced every 2–3 days until the cells reached 80% confluency. Confluent cells were trypsinized and subcultured, and cells at passage 3–6 were used for the study. For the 3D culture, different peptides were sterilized by exposure to UV light for 30 min. Then, 200 μL of 3D constructs in the 48-well plate was formed by mixing the peptide solution (IVZK = 3 mg/mL (5.42 mM); IVFK = 4 mg/mL (7.31 mM)) with 40 000 cells suspended in 2× PBS. Culture plates were incubated for 5 min at 37 °C, and the complete medium was added carefully to the culture plates. The constructs were then cultured with osteogenic induction media or basal stem cell growth media. The morphology, cell proliferation, and mineralization of the cells in each scaffold were analyzed and compared. The efficiency of osteogenic differentiation was also compared with a traditional 2D culture. As positive controls, cells cultured in a collagen scaffold were used because Matrigel degrades after 2 weeks due to which we cannot keep it for the entire differentiation time (3–4 weeks). Also, collagen is considered as a positive 3D scaffold in osteogenic differentiation. The negative control was the cell from the same passage grown in a basal medium without osteogenic supplements. alamarBlue and CellTiter-Glo luminescent 3D cell viability assays were performed to evaluate the cytotoxicity and proliferation of cells. Flow cytometry was performed to study the expression of stem cell markers. Detailed information is provided in the Experimental Section, Supporting Information.
Cell Invasion Assay
A previous cell invasion assay protocol was followed.50 Briefly, cells (30 000) were added to 2 μL of fibrin solution (2 mg/mL fibrinogen and 2.5 U/mL thrombin). The clusters were incubated for 30 min at 37 °C for polymerization. Then, clusters were transferred into a peptide gel (20 μL) by placing them inside the gel. The gel was made by mixing 10 μL of peptide solution and 10 μL of PBS 2× and incubated for 15 min for solidification. Cells were imaged to quantify cell migration out of the fibrin clot.
Cytoskeletal and Antiosteocalcin Staining
Immunostaining was performed after each time point of culture. Briefly, cells were fixed by 4% paraformaldehyde solution for 30 min and incubated in a cold cytoskeleton buffer (3 mM MgCl2, 300 mM sucrose, and 0.5% Triton X-100 in PBS solution) for 5 min to permeabilize the membranes of the cells. The permeabilized cells were incubated in a blocking buffer solution, 5% fetal bovine serum (FBS), 0.1% Tween-20, and 0.02% sodium azide in PBS for 30 min. For antiosteocalcin, the dye was diluted in PBS (1:80) and incubated for 1 h at room temperature, followed by incubation with a secondary antibody conjugated with Alexa Fluor 488, 1:500 (green). For F-actin, rhodamine–phalloidin (1:300) was added to the cells for 1 h. Further, the cells were incubated in 4′,6-diamidino-2-phenylindole (DAPI) for 5 min to counterstain the nucleus. The fluorescent-dye-treated cells were observed and imaged using a laser scanning confocal microscope (Zeiss LSM 710 inverted confocal microscope, Germany).
Alkaline Phosphatase Assay
Alkaline phosphatase (ALP) was measured after 1 and 2 weeks of culture using an alkaline phosphatase substrate kit. At the end of each culture time, the scaffolds were washed by PBS and cells were lysed using 1% Triton X-100. Then, 80 μL of the cell lysate mixture was added to 50 μL of the para-nitrophenylphosphate (pNPP) substrate (5 mM) and incubated at room temperature for 2 h. The reaction was inhibited by the addition of a stop solution, and the absorbance was measured at 405 nm using a multimode plate reader (PHERAstar FS, Germany).
Alizarin Red Staining
After 14 days of culture, the media were removed and the cells were washed three times with PBS, fixed with 4% paraformaldehyde, and incubated for 15 min at room temperature. Detailed information is provided in the Experimental Section, Supporting Information.
Quantitative Real-Time Polymerase Chain Reaction (RT-PCR)
The BM-MSCs were cultured on different scaffolds with an osteogenic medium for 4 weeks. Total RNA was extracted using the TRIzol reagent. RNA concentration and purity were measured using a NanoDrop 8000 spectrophotometer (Thermo Fisher). Complementary DNA (cDNA) was synthesized using the ImProm-II Reverse Transcription System. Primer sequences were taken from previously published studies and are summarized in Table 1. Relative quantification was performed using the comparative CT (2-ΔΔCT) and normalized against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which was used as a housekeeping gene to calculate the fold change in gene expression. BM-MSCs on a 2D culture using basal media were used as controls.
Table 1. Primers Used to Modify Bone-Specific Genes.
gene | primer sequence |
---|---|
ALP | forward 5-GCACCTGCCTTACTAACTC-3 |
reverse 5-AGACACCCATCCCATCTC-3 | |
IBSP | F CACTGGAGCCAATGCAGAAGA |
R TGGTGGGGTTGTAGGTTCAA | |
BMP-2 | F 5-TGCGGTCTCCTAAAGGTC-3 |
R 5-AACTCGAACTCGCTCAGG-3 | |
RUNX2 | F TCAACGATCTGAGATTTGTGGG |
R GGGGAGGATTTGTGAAGACGG | |
osteopontin | F GAAGTTTCGCAGACCTGACAT |
R GTATGCACCATTCAACTCCTCG |
In Vitro Angiogenesis Study
Peptide hydrogel or collagen was placed in a 24-well plate, and human umbilical vein endothelial cells (HUVECs) at 40 000 cells/well were added on top of the peptide gel or collagen. Cells were cultured in endothelial growth media for 24 h. Cells were then investigated using an inverted microscope, and images were analyzed by ImageJ using the Angiogenesis Analyzer.
Statistical Analysis
Results are represented as mean ± standard deviation (SD), n ≥ 3. The differences observed in the BM-MSC behavior between different scaffolds were compared; statistical analysis was performed using a Student t-test, and values with p < 0.05 were considered to be statistically significant.
Results and Discussion
Self-Assembling Ultrashort Tetrapeptides
Two self-assembling tetrapeptides, aromatic IVFK and nonaromatic IVZK, had been rationally designed based on a previous report of the positive impact of lysine (Lys, K) containing peptide hydrogels on cell expansion.44,51 The positively charged amine group from the lysine residue and the polarity of the surface have been reported to mediate cell adhesion and spreading.52,53 These peptides are composed of a positively charged amino acid (Lys) in the C-terminal and three nonpolar amino acids as a hydrophobic tail. Due to their amphiphilic structure, both peptides are able to self-assemble to form ordered aggregates.52−54 The aggregation rate of the peptides can be enhanced by alternating the aromatic phenylalanine (Phe, F) residue in IVFK with more hydrophobic, nonaromatic cyclohexylalanine (Cha, Z) as can be found in IVZK.55
Two-dimensional (2D) NMR experiments, such as correlation spectroscopy (COSY), total correlation spectroscopy (TOCSY), and nuclear Overhauser enhancement spectroscopy (NOESY), were then performed to analyze the spatial arrangement of the peptide molecule in water due to the self-assembly (Figures S3–S6 and Tables S1 and S2). We determined the intermolecular cross-peaks by eliminating the NOESY spectra that overlap with TOCSY spectra. Using this approach, we observed two nuclear Overhauser effect (NOE) signals from IVFK, in which one of them was assigned to the ε proton of Lys and the δ proton of the Ile. Another signal was arising from the interaction between β protons of phenylalanine with the γ proton of Ile. From these NOESY spectra, we proposed a formation of antiparallel configuration for IVFK. In addition, this antiparallel conformation was also predicted in IVZK as the amide proton of cyclohexylalanine interacts with the α proton of isoleucine (Ile, I). This result is congruent with the previous report on the formation of antiparallel conformation during the self-assembly of ultrashort peptides.44,49
Furthermore, we observed an instant hydrogel formation when PBS buffer was added to the peptide solution. To monitor the gelation time, a vial inversion test was performed at different peptide concentrations in 1× PBS to meet physiological conditions (Figures 1A and S7). Compared to IVFK, IVZK needed less time to form the hydrogel. This is most likely due to the presence of the highly hydrophobic cyclohexylalanine residue, which increases the aggregation rate.44,56
Figure 1.
Self-assembling peptide hydrogels. The self-assembling peptides IVFK and IVZK at the critical gelation concentration (CGC) of 2 mg/mL generate supramolecular nanofibrous hydrogels in an aqueous solution. (a) The gelation was formed in 1× phosphate-buffered saline. The morphology of the nanofibrous hydrogels studied was imaged at magnifications of 100 000× and 500 000× (inset) using SEM: (b) 4 mg/mL IVFK and (c) 3 mg/mL IVZK. Scale bars are 1 μm and 200 nm (inset). (d) The porosity of the peptide hydrogels was calculated from the SEM images of both peptides at low concentrations (4 mg/mL IVFK and 3 mg/mL IVZK) and high concentrations (8 mg/mL for both peptides). (e) The mechanical stiffness values of the two peptide hydrogels IVFK and IVZK were measured at 1 rad/s and 0.1% strain.
The morphology of the hydrogels was evaluated by performing SEM of dried hydrogels. The SEM micrographs confirmed the presence of porous fiber networks formed by the entanglement of self-assembled peptide nanofibers (Figures 1b,c and S8). This porous structure is vital to the diffusion of necessary nutrients for cell growth. We then compared the porosity of the hydrogels at low concentrations (4 mg/mL for IVFK and 3 mg/mL for IVZK) and high concentrations (8 mg/mL for both peptides). The results suggest that the increment of the peptide hydrogel reduced the porosity by 8% for both peptides (Figures 1d and S8). The dimensions of the pores (nanometer-scale) are far smaller than the cell’s nucleus dimensions, which might then restrict the passive cell movement. Under this condition, the cellular motility can be accommodated by either mechanically distorting the surrounding matrix57 or squeezing the cell morphology.58−62 It has been previously reported that the porosity of a planar matrix with a nanometer-scale did not significantly affect the differentiation of stem cells, but the stiffness of the matrix regulates the differentiation.63
Mechanical Stiffness of Peptide Hydrogels
The mechanical stiffness of each peptide hydrogel was assessed by the storage modulus (G′) at different concentrations. As seen in Figure 1e and Table S3, the stiffness of the peptide hydrogels increases as the peptide concentration increases. The IVZK hydrogel showed a higher G′ value compared to IVFK at the same concentration, which is most likely due to the hydrophobic cyclohexylalanine residue in IVZK. Remarkably, the stiffness range of both peptide hydrogels was found to be within the range that supports multipotency maintenance.51 Therefore, these self-assembled peptide hydrogels were proposed to be promising candidates for use as cell-laden scaffolds in an osteogenic model.
Viability, Attachment, and Proliferation of BM-MSCs in Scaffolds
After studying the inherent properties of the assembled peptide scaffolds, the hydrogels were screened for biocompatibility, cell attachment, and proliferation. Different concentrations of the peptides were used to study the biocompatibility of the cells within the constructs (Figure 2a). The results showed that no cytotoxicity effect was observed. Furthermore, IVFK showed a significant increase in cell growth compared to both controls (2D and Matrigel). Furthermore, a live/dead cytotoxicity assay was performed to evaluate the biocompatibility of MSCs in the peptides after different time points, as shown in Figure 2b. The results showed a high percentage of cell viability and increase in the cell growth rate during the culture time, thus indicating that there is no cytotoxicity associated with the peptides tested with the cells (Videos S1 and S2). Cell attachment and spreading into the hydrogels were observed within 24 h, 48 h, and 7 days, as shown in the bright-field microscopy images in Figure S9. The light micrographs showed long spindlelike cells spreading in all of the scaffolds tested. With culture time increasing, the cell growth increased in both peptides and the cells were observed to start spreading to form the spindle morphology. After 14 days in culture, most of the scaffolds were covered by cells (Figure S9). SEM images for MSCs cultured after 14 days in IVFK or IVZK showed clearly the elongated spindlelike morphology of the cells and the interaction between the cell’s filopodia and the matrix (Figure 2c). Furthermore, we also estimated the cell growth of MSCs in these peptide scaffolds by examining adenosine 5′-triphosphate (ATP) release after 1 and 7 days of culture (Figure 2d). ATP production increased with time of culture, indicating the proliferation of the cells among different peptides, which is comparable to the controls.
Figure 2.
Cell biocompatibility, attachment, and proliferation. Cell viability as influenced by various concentrations of peptide solutions. The cells were incubated for 48 h with the peptides and without peptides as the control. (a) The cell viability was assessed using the alamarBlue assay. (b) Live/dead cell viability staining images of BM-MSCs within IVFK and IVZK peptide hydrogels. Cells were stained with calcein-AM (green, live cells) and ethidium homodimer-1 (red, dead cells). Scale bar is 100 μm. (c) SEM images of BM-MSCs in IVFK and IVZK; scale bars are 5 and 10 μm, respectively. (d) Three-dimensional cell viability assay of BM-MSCs in IVFK and IVZK after 1 and 7 days of culture.
Characterization of BM-MSCs in Scaffolds
To identify if the cells maintained their multipotency and capacity for self-renewal, MSCs were evaluated for two surface markers (CD73 and CD105) by flow cytometry. CD73 is a major cell surface marker defining MSCs. Interestingly, the CD73 expression is regulated by one of the main pathways in bone homeostasis.64,65 CD73 has recently been reported to have an important role in supporting osteogenic differentiation.66 Endoglin CD105 is another MSC marker that plays an important role in the processes of cell proliferation, differentiation, and migration. Gazit et al. demonstrated that CD105-positive MSCs are multipotent in vitro and can support bone formation in vivo.67 As such, we studied the CD105 and CD73 expressions through flow cytometry after 3 days of culture. In both scaffolds tested, the cells expressed their native CD105 and CD73, which suggests that the cells maintained their multipotency within the hydrogels (Figure S10). In addition, MSCs were entrapped in the fibrin clot and embedded within the gels to evaluate the ability of cells to migrate toward the surrounding environment (hydrogels). A previous study reported that cells failed to migrate to the hydrogel without RGD.50 Interestingly, cells were able to migrate radially out of the fibrin clot into hydrogels without any further functionalization and showed spindlelike shapes (Figure 4a). Confocal laser microscopy with nuclei and actin staining revealed clearly that the migration of these cells occurred.
Figure 4.
Osteogenic differentiation of MSCs in each scaffold. (a) Phase-contrast image of MSCs cultured in different hydrogels in osteogenic media after 7 and 14 days, which clearly showed the mineralization; scale bar is 100 μm. (b) Alizarin red-S staining of four scaffolds; scale bar is 100 μm. (c) In vitro morphology of hMSCs after 3 weeks of culturing. The cells displayed a highly branched “osteocyte-like” shape. Red represents the actin filaments, and blue represents the cell nuclei; scale bar is 50 μm.
The extracellular matrix plays an essential role in several factors affecting a cell’s life such as proliferation and viability.68 In addition to differences in cell growth and viability, cells discriminate between matrices by controlling the level of tension in cell binding and then responding with counteracting forces. To further study how the cells responded to different scaffolds, immunostaining of the actin cytoskeleton was performed. Focal adhesions (FAs) act as force sensors between cells and their surrounding matrix through anchored actin microfilament bundles.69,70 As such, the cells were immunostained with F-actin using phalloidin to label the cytoskeletal arrangement. BM-MSCs were cultured in each peptide hydrogel studied earlier as well as in 2D culture and Matrigel as controls. The cells were able to attach to both scaffolds without any observed changes in their morphological appearance. The cells maintained their spindle morphology, spread in all directions, exhibited a meshlike/extended actin, and made a sheet of cells covering every part of scaffolds as shown in (Figure 3b).
Figure 3.
Characterization of BM-MSCs in scaffolds. (a) Migration assay: F-actin was stained with phalloidin (red) and the nucleus with DAPI (blue), scale bar is 100 μm. (b) Morphological studies of the BM-MSCs allowed for the assessment of their ability to develop well-organized actin cytoskeletons through actin immunostaining (red) and cell–matrix adhesion by stained vinculin (green) and DAPI for the nucleus (blue). Scale bar is 100 μm.
Many studies have been performed on coated 2D surfaces that are not physiologically relevant,71−73 thus not providing an accurate reflection of the state of the cells. In contrast, 3D cultures may more closely mimic the natural cell environment and provide cells with the required stiffness conditions. One of these studies found that cells that grew on a 2D surface coated with collagen showed less actin cytoskeleton organization when compared to cells grown on a stiffer material.74 Furthermore, Tan et al. indicated that the cells cultured in stiff 3D matrices like transglutaminase cross-linked gelatin (TG-gel) with reported stiffnesses of 58 and 34 kPa formed dotlike actin filaments, and the cells did not spread through the scaffold.75 However, in this study, we found that all of the matrices supported a well-established cytoskeleton with an elongated arrangement (Figure 3b). One possible explanation for these observations is that in a 2D culture, cells are directed from the latitudinal direction only, thus allowing them the possibility to extend extremely along the longitudinal direction. On the other hand, the cells cultured in a 3D environment are grown in two directions, longitudinal and latitudinal.75 As such, the actin filaments of the cells in the 3D matrix showed better arrangement when compared to those grown in a 2D culture. Given that 3D environments provide an extra dimension for exterior mechanical responses and cell attachment, they can affect cell spreading, cell contraction, and intracellular signaling.76,77 Thus, the cells on 2D surfaces are less mechanically sensitive than those in 3D environments.75 Furthermore, the cells cultured in hydrogels were found to have a similar F-actin organization trend as in Matrigel.
Vinculin is an adhesion protein located in the cell–cell junctions and in focal adhesions (FAs), where it helps with the actin cytoskeleton connection to ECM.64,65 The effects of vinculin on the migratory behavior of cells in 3D collagen were reported. Deficiency in vinculin affected cell adhesion, contractility, and proliferation.78 The confocal fluorescence images of actin cytoskeleton and vinculin for the cells in IVFK, IVZK hydrogels, and Matrigel are shown in Figure 3b. In the 2D study, the cells appeared to be more spread out. However, in 3D culture, cells showed a smaller cell spreading area. While a previous report has shown that there is no enzymatic activity of vinculin, it can bind to actin, thereby activating actin polymerization.65 Most importantly, the distribution of vinculin was concentrated around the nuclear region, rather than being aligned with actin.79−81
Osteogenic Differentiation of MSCs in Self-Assembled Peptides
The proliferation and attachment of MSCs were investigated in the three-dimensional network of various hydrogels. Next, we evaluated the ability of our hydrogels to support the osteogenic differentiation of MSCs. Cells were cultured in both hydrogels under the osteogenic condition for 3 weeks, and the efficiency of differentiation was compared to collagen. Collagen is an essential component of the ECM, which has been used widely as an important component of scaffolds in tissue engineering and is known to support both osteogenic differentiation of MSCs and angiogenesis of endothelial cells.23
The osteogenic differentiation potential of BM-MSCs in the hydrogels was observed, and bright-field images were taken after 7 and 14 days of culture. The morphology of cells changed several days after the addition of osteogenic induction media with the mineralization clearly observed as a black aggregate after 14 days. Also, MSCs exhibited a highly branched “osteocyte-like” shape, shown by bright-field images and more clearly by confocal fluorescence images of the F-actin cytoskeleton of the cells. This branched shape is correlated with the differentiation of stem cells toward an osteogenic lineage, which indicates that the cells successfully differentiated in both scaffolds (Figures 4a,c and S11a).82−84
Alizarin red staining (ARS) was used to detect calcium deposition. The BM-MSCs cultured in the different scaffolds in the osteogenic medium were stained by Alizarin red to confirm the mineralization process during osteogenic differentiation (Figures 4b and S11b). There were detectable mineral deposits, which are seen as small, stained nodules in dark-red/black color. This indicates the presence of calcium deposits. The mineral produced by the cells cultured in the IVFK hydrogel in the osteogenic medium produced the most intense ARS staining when compared to the other scaffolds tested. These results showed that IVFK could accelerate the production of calcium and regulate the calcification progression of the bone matrix.
Further confirmation was done to prove the differentiation of BM-MSCs to the osteogenic lineage; the expression of osteocalcin was stained and imaged after 3 weeks of culture using confocal microscopy (Figure 5a). While the MSCs cultured in both scaffolds were able to express osteocalcin, the expression levels in IVFK were comparable to those cultured in the collagen control group. Additionally, the levels of alkaline phosphatase (ALP), an early osteogenic marker expressed by osteoblast cells, were measured to confirm the commitment of BM-MSCs toward the osteogenic lineage. The results below (Figure 5b) show the time course of ALP activity in MSCs cultured on 2D and in different scaffolds: collagen, IVFK, and IVZK after 7 and 14 days. Significantly higher ALP activity was detected for MSCs cultured in the IVFK hydrogel than in those cultured in collagen after 7 days (p < 0.05). Furthermore, the ALP activity increased with time during the initial 2 weeks as an indicator of osteogenic differentiation.
Figure 5.
Osteogenic differentiation of BM-MSCs in scaffolds. (a) Confocal images showed the expression of osteocalcin in green, and the cell nuclei were stained using DAPI; scale bar is 100 μm. (b) ALP activity of BM-MSCs cultured on scaffolds in the osteogenic medium for 7 and 14 days. All values are expressed as mean ± SD from three different replicates. Statistical significance of *p < 0.05.
Gene Expression Analysis
Real-time polymerase chain reaction (PCR) values of the BM-MSC gene expressions of the bone morphogenetic protein (BMP-2), bone sialoprotein 2 (IBSP), osteopontin (OPN), osterix (OSX), and RUNX2 were evaluated after 30 days of culture (Figure 6). Runx2 is an early marker of osteogenic differentiation.85 The increase in Runx286 indicates that the MSCs were being directed toward the bone lineage.1 The expression of Runx2 was higher in IVFK when compared to cells cultured in other groups.
Figure 6.
Osteogenic-related gene expression of BM-MSCs cultured on different scaffolds after 30 days. Data analysis and relative quantitation were performed using the comparative CT (ΔΔCT) method. Statistical significance of *p < 0.05 and **p < 0.001.
BMP-2 is a glycoprotein that is responsible for the differentiation of osteoblasts, thereby helping in bone formation.87 It is known that the expression of BMP-2 is upregulated in hMSCs during osteogenic differentiation.88,89 The expression was upregulated in both peptide scaffolds as well as in collagen and 2D.
OPN and IBSP are considered as late osteogenic markers, and their expression is known to be increased to induce osteoblast differentiation toward mature osteocyte.90 Osteopontin (OPN) is one of the most plentiful noncollagenous proteins in the bone. OPN plays an important role in differentiating osteoclasts and in recruiting and functioning osteoblasts.91 OPN was also found to help in osteoclast migration toward sites of resorption and is essential for normal resorption and bone turnover.92 The expression of this gene was measured and found to be downregulated in 2D and IVZK hydrogels. However, importantly, the expression of ONP was upregulated in cells cultured in IVFK as well as in collagen, which indicates the maturation of osteocyte. In addition, the IBSP gene expression level was found to be the highest in the IVFK scaffold. Finally, we found that the expression level of OSX, which is decreased in the final maturation phase of osteogenic differentiation,90 was low in IVFK compared to other groups and downregulated in cells cultured in collagen. These findings clearly point to the osteogenic differentiation advantages offered by the IVFK peptide hydrogel.
Effect of Matrix Stiffness on Osteogenic Differentiation
Cells are sensitive to many factors, which may, in turn, affect their growth, maturation, and differentiation. These factors include chemical stimuli like growth factors and other factors.93−96 Furthermore, the mechanical properties of the extracellular matrix, like rigidity, elastic modulus, and porosity, also have a significant impact.97−99 Mechanical properties have been reported to have a substantial effect on regulating the stem cell fate.100 For example, cells cultured inside hydrogel scaffolds with elastic moduli in ranges of 11–30 and 2.5–5 kPa directed MSC differentiation into osteogenic and adipogenic lineages, respectively.101
Based on the cell attachment, proliferation, and calcium deposition results obtained earlier, we selected the IVFK scaffold to be used in the subsequent bone differentiation studies. Therefore, osteogenic differentiation of BM-MSCs in IVFK hydrogels of different stiffnesses was evaluated using the alkaline phosphatase (ALP) activity assay, Alizarin red-S staining, and osteocalcin staining and by measurement of osteogenic transcription levels (Figure 7).
Figure 7.
Osteogenic differentiation of BM-MSCs in the IVFK hydrogel with two different stiffnesses (20 and 50 kPa). (a) Quantification of mineralization by Alizarin red-S after 14 and 21 days of culture and ALP activity of BM-MSCs after 7 and 14 days. (b) Confocal images of osteocalcin produced by differentiated cells in different scaffolds; the cell nuclei were stained using DAPI. (c) Osteogenic-related gene expression by RT-PCR of BM-MSCs cultured within scaffolds with different stiffnesses. All values are expressed as mean ± SD from three different replicates. Statistical significance of *p < 0.05, **p < 0.01, and ****p < 0.0001.
The mechanical properties of the peptide hydrogel can easily be tuned by increasing the peptide concentration. However, caution should be administered as increasing the peptide concentration will affect the peptide hydrogel’s physical parameters, such as porosity and diffusion of nutrients, affecting the cell viability and proliferation.102−104 To study the effect of peptide hydrogel stiffness on MSC differentiation, two concentrations of IVFK were investigated. Peptide concentrations of 4 and 8 mg/mL resulted in stiffnesses of around 20 and 50 kPa, respectively. Analyses of the calcium content and ALP release after 7 and 14 days, respectively, revealed that the value of the hydrogel with a storage modulus of around 20 kPa possessed a significantly higher calcium content and ALP release than that at 50 kPa (Figure 7a). The osteocalcin expression was found to be more intense in the 20 kPa scaffold compared to the others (Figure 7b). Finally, the expression of two osteogenic genes showed that the hydrogel with a reported stiffness of 20 kPa was able to support cell differentiation much better than the 50 kPa scaffold (Figure 7c). This result is consistent with that of previous studies that reported that stiff matrices (16–25 kPa) lead MSCs to be differentiated to the osteoblast.105,106 Also, another group reported that cells cultured inside a hydrogel with stiffness 11–30 kPa directed MSC differentiation into the osteogenic lineage.101 The results suggest that matrix stiffness plays an important role in cell differentiation.
Angiogenesis Ability In Vitro
When bone deficiency occurs, it often causes blood vessel damage. Blood vessels provide the necessary components to repair the region of bone defects by transferring oxygen and nutrients.107,108 Because the capillary system is a crucial component in bone regeneration, the capability of IVFK and IVZK hydrogels (Figure S12) to support angiogenesis was also evaluated using HUVECs and compared with collagen, which is an essential component of the ECM and is known to support the angiogenesis of endothelial cells.23 As indicated in Figure 8a, after 24 h of culture, HUVECs were observed under the microscope, and dense network structures were found in HUVECs cultured in the hydrogel similar to the collagen control. Additionally, the junctions, nodes, and the total length of tubes were analyzed by ImageJ, as shown in Figure 8b. No significant difference was found between IVFK and the positive control. This result indicates that the IVFK scaffold has the ability to promote angiogenesis of HUVECs in vitro.
Figure 8.
Angiogenesis ability of the IVFK scaffold in vitro. (a) Calcein-AM (green) and ethidium homodimer (red) staining, and bright-field image of HUVECs after 24 h; scale bar is 100 μm. (b) Quantification of angiogenesis by measuring vessel junctions, number of nodes, and the total vessel length for five different pictures.
Conclusions
This work provides evidence of the successful preparation of an ultrashort, amphiphilic peptide hydrogel capable of promoting osteogenic differentiation and angiogenesis. In contrast with the traditional 2D cell culture, cells maintained in a 3D culture more closely mimic the in vivo setting. This is particularly true with respect to cell shape and organization, as well as the extracellular environment, which may have a substantial impact on cell behavior. This study aimed to investigate the potential of two peptide scaffold materials in supporting the adhesion, proliferation, and osteogenic differentiation of BM-MSCs. These hydrogels are easy to prepare and solidify quickly to provide a 3D environment. Furthermore, they have good mechanical properties, and they provide a well-defined molecule that can be adapted to include a wide range of chemical moieties. The fiber networks of the two hydrogels were found to resemble that of the native ECM while providing adhesion and proliferation cues for the BM-MSCs. Our hydrogels were biocompatible and promoted cell migration, osteogenic differentiation, and angiogenesis. Cells cultured in the IVFK hydrogel showed an increase in ALP production, an enhanced expression of osteogenic markers, and mineralization. Furthermore, the mechanical properties of the hydrogel can be modulated by changing the peptide concentration, which was found to influence cell behavior as well. Thus, our hydrogel supports both osteogenic differentiation and angiogenesis and could potentially be used as a scaffold in bone tissue engineering. Importantly, it provides valuable insights into the design of hydrogels for 3D stem cell culture in the future.
Acknowledgments
This work was financially supported by the King Abdullah University of Science and Technology. The authors acknowledge Dr. Abdul-Hamid Emwas for NMR support. The authors acknowledge Sarah Ghalayini for proofreading. The graphical abstract was created with BioRender.com.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biomac.1c00205.
Materials and methods; liquid chromatograms and mass spectra of IVFK and IVZK (Figures S1 and S2); 1H NMR spectra of IVFK and IVZK in d6-dimethyl sulfoxide (d6-DMSO) (Figure S3); 2D NMR (COSY, TOCSY, NOESY) spectra of IVFK and IVZK in H2O/D2O 9:1 (Figures S4–S6 and Tables S1 and S2); vial inversion test for both IVFK and IVZK at different concentrations (Figure S7); porosity of peptide hydrogels (Figure S8); rheological properties of peptide hydrogels at different concentrations (Table S3); phase-contrast images of BM-MSCs cultured in different scaffolds up to 14 days (Figure S9); characterization of BM-MSCs in scaffolds; BM-MSCs stained against CD73 and CD105; data showing the positive expression of MSC-associated surface antigens CD73 and CD105 (Figure S10); BM-MSCs cultured in normal basal media (Figure S11); and angiogenesis ability of the IVZK scaffold in vitro (Figure S12) (PDF)
BM-MSCs cultured within IVFK for 4 days (Video S1) (AVI)
BM-MSCs cultured within IVZK for 4 days (Video S2) (AVI)
Author Contributions
C.A.E.H. proposed the research direction and guided the project. S.A. designed and performed the majority of the experimental parts. The peptide characterization was done by H.H.S. S.A. wrote the manuscript. The authors have given approval to the final version of the manuscript.
The authors declare no competing financial interest.
Supplementary Material
References
- Gauthaman K.; Venugopal J. R.; Yee F. C.; Biswas A.; Ramakrishna S.; Bongso A. Osteogenic differentiation of human Wharton’s jelly stem cells on nanofibrous substrates in vitro. Tissue Eng., Part A 2011, 17, 71–81. 10.1089/ten.tea.2010.0224. [DOI] [PubMed] [Google Scholar]
- Leng Q.; Chen L.; Lv Y. RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA. Theranostics 2020, 10, 3190. 10.7150/thno.42640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erdem A.; Darabi M. A.; Nasiri R.; Sangabathuni S.; Ertas Y. N.; Alem H.; Hosseini V.; Shamloo A.; Nasr A. S.; Ahadian S. 3D Bioprinting of Oxygenated Cell-Laden Gelatin Methacryloyl Constructs. Adv. Healthcare Mater. 2020, 9, 1901794 10.1002/adhm.201901794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myeroff C.; Archdeacon M. Autogenous bone graft: donor sites and techniques. J. Bone Jt. Surg. 2011, 93, 2227–2236. 10.2106/JBJS.J.01513. [DOI] [PubMed] [Google Scholar]
- Silbernagel N.; Körner A.; Balitzki J.; Jaggy M.; Bertels S.; Richter B.; Hippler M.; Hellwig A.; Hecker M.; Bastmeyer M.; Ullrich N. D. Shaping the Heart: Structural and Functional Maturation of iPSC-Cardiomyocytes in 3D-Micro-Scaffolds. Biomaterials 2020, 227, 119551 10.1016/j.biomaterials.2019.119551. [DOI] [PubMed] [Google Scholar]
- Silber J. S.; Anderson D. G.; Daffner S. D.; Brislin B. T.; Leland J. M.; Hilibrand A. S.; Vaccaro A. R.; Albert T. J. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003, 28, 134–139. 10.1097/00007632-200301150-00008. [DOI] [PubMed] [Google Scholar]
- Alonzo M.; Alvarez Primo F.; Anil Kumar S.; Mudloff J. A.; Dominguez E.; Fregoso G.; Ortiz N.; Weiss W. M.; Joddar B. Bone tissue engineering techniques, advances, and scaffolds for treatment of bone defects. Curr. Opin. Biomed. Eng. 2021, 17, 100248 10.1016/j.cobme.2020.100248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amini A. R.; Laurencin C. T.; Nukavarapu S. P. Bone tissue engineering: recent advances and challenges. Crit. Rev. Biomed. Eng. 2012, 40, 363–408. 10.1615/CritRevBiomedEng.v40.i5.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bharadwaz A.; Jayasuriya A. C. Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration. Mater. Sci. Eng., C 2020, 110, 110698 10.1016/j.msec.2020.110698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pittenger M. F.; Mackay A. M.; Beck S. C.; Jaiswal R. K.; Douglas R.; Mosca J. D.; Moorman M. A.; Simonetti D. W.; Craig S.; Marshak D. R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143–147. 10.1126/science.284.5411.143. [DOI] [PubMed] [Google Scholar]
- Ma K.; Laco F.; Ramakrishna S.; Liao S.; Chan C. K. Differentiation of bone marrow-derived mesenchymal stem cells into multi-layered epidermis-like cells in 3D organotypic coculture. Biomaterials 2009, 30, 3251–3258. 10.1016/j.biomaterials.2009.02.025. [DOI] [PubMed] [Google Scholar]
- Petite H.; Viateau V.; Bensaid W.; Meunier A.; de Pollak C.; Bourguignon M.; Oudina K.; Sedel L.; Guillemin G. Tissue-engineered bone regeneration. Nat. Biotechnol. 2000, 18, 959. 10.1038/79449. [DOI] [PubMed] [Google Scholar]
- Takamine Y.; Tsuchiya H.; Kitakoji T.; Kurita K.; Ono Y.; Ohshima Y.; Kitoh H.; Ishiguro N.; Iwata H. Distraction osteogenesis enhanced by osteoblastlike cells and collagen gel. Clin. Orthop. Relat. Res. 2002, 399, 240–246. 10.1097/00003086-200206000-00029. [DOI] [PubMed] [Google Scholar]
- Kofidis T.; Lebl D. R.; Martinez E. C.; Hoyt G.; Tanaka M.; Robbins R. C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005, 112, I-173–I-177. 10.1161/CIRCULATIONAHA.104.526178. [DOI] [PubMed] [Google Scholar]
- Yildirim Y.; Naito H.; Didié M.; Karikkineth B. C.; Biermann D.; Eschenhagen T.; Zimmermann W.-H. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007, 116, I-16–I-23. 10.1161/CIRCULATIONAHA.106.679688. [DOI] [PubMed] [Google Scholar]
- Radisic M.; Park H.; Shing H.; Consi T.; Schoen F. J.; Langer R.; Freed L. E.; Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 18129–18134. 10.1073/pnas.0407817101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spadaccio C.; Chachques E.; Chello M.; Covino E.; Chachques J. C.; Genovese J. Predifferentiated adult stem cells and matrices for cardiac cell therapy. Asian Cardiovasc. Thorac. Ann. 2010, 18, 79–87. 10.1177/0218492309355836. [DOI] [PubMed] [Google Scholar]
- Kutschka I.; Chen I. Y.; Kofidis T.; Arai T.; Von Degenfeld G.; Sheikh A. Y.; Hendry S. L.; Pearl J.; Hoyt G.; Sista R.; et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006, 114, I-167–I-173. 10.1161/CIRCULATIONAHA.105.001297. [DOI] [PubMed] [Google Scholar]
- Orkin R.; Gehron P.; Mcgoodwin E. B.; Martin G.; Valentine T.; Swarm R. A murine tumor producing a matrix of basement membrane. J. Exp. Med. 1977, 145, 204–220. 10.1084/jem.145.1.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sethi T.; Rintoul R. C.; Moore S. M.; MacKinnon A. C.; Salter D.; Choo C.; Chilvers E. R.; Dransfield I.; Donnelly S. C.; Strieter R.; et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 1999, 5, 662–668. 10.1038/9511. [DOI] [PubMed] [Google Scholar]
- Grant D.; Kibbey M.; Kinsella J.; Cid M.; Kleinman H. The role of basement membrane in angiogenesis and tumor growth. Pathol., Res. Pract. 1994, 190, 854–863. 10.1016/S0344-0338(11)80989-1. [DOI] [PubMed] [Google Scholar]
- Fushimi H.; Hiratsuka T.; Okamura A.; Ono Y.; Ogura I.; Nishimura I. Recombinant collagen polypeptide as a versatile bone graft biomaterial. Commun. Mater. 2020, 1, 1 10.1038/s43246-019-0005-6. [DOI] [PubMed] [Google Scholar]
- Kang P. L.; Huang H. H.; Chen T.; Ju K. C.; Kuo S. M. Angiogenesis-promoting effect of LIPUS on hADSCs and HUVECs cultured on collagen/hyaluronan scaffolds. Mater. Sci. Eng., C 2019, 102, 22–33. 10.1016/j.msec.2019.04.045. [DOI] [PubMed] [Google Scholar]
- Blokhuis T.; Arts J. C. Bioactive and osteoinductive bone graft substitutes: definitions, facts and myths. Injury 2011, 42, S26–S29. 10.1016/j.injury.2011.06.010. [DOI] [PubMed] [Google Scholar]
- Barradas A.; Yuan H.; van Blitterswijk C. A.; Habibovic P. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. Eur. Cells Mater. 2011, 21, 407–429. 10.22203/eCM.v021a31. [DOI] [PubMed] [Google Scholar]
- Habibovic P.; de Groot K. Osteoinductive biomaterials—properties and relevance in bone repair. J. Tissue Eng. Regener. Med. 2007, 1, 25–32. 10.1002/term.5. [DOI] [PubMed] [Google Scholar]
- Ramier J.; Grande D.; Bouderlique T.; Stoilova O.; Manolova N.; Rashkov I.; Langlois V.; Albanese P.; Renard E. From design of bio-based biocomposite electrospun scaffolds to osteogenic differentiation of human mesenchymal stromal cells. J. Mater. Sci. Mater. Med. 2014, 25, 1563–1575. 10.1007/s10856-014-5174-8. [DOI] [PubMed] [Google Scholar]
- Adler-Abramovich L.; Gazit E. The physical properties of supramolecular peptide assemblies: from building block association to technological applications. Chem. Soc. Rev. 2014, 43, 6881–6893. 10.1039/C4CS00164H. [DOI] [PubMed] [Google Scholar]
- Biesalski M. A.; Knaebel A.; Tu R.; Tirrell M. Cell adhesion on a polymerized peptide–amphiphile monolayer. Biomaterials 2006, 27, 1259–1269. 10.1016/j.biomaterials.2005.08.002. [DOI] [PubMed] [Google Scholar]
- Mata A.; Hsu L.; Capito R.; Aparicio C.; Henrikson K.; Stupp S. I. Micropatterning of bioactive self-assembling gels. Soft Matter 2009, 5, 1228–1236. 10.1039/b819002j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eren E. D.; Tansik G.; Tekinay A. B.; Guler M. O. Mineralized peptide nanofiber gels for enhanced osteogenic differentiation. ChemNanoMat 2018, 4, 837–845. 10.1002/cnma.201700354. [DOI] [Google Scholar]
- Mata A.; Geng Y.; Henrikson K. J.; Aparicio C.; Stock S. R.; Satcher R. L.; Stupp S. I. Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix. Biomaterials 2010, 31, 6004–6012. 10.1016/j.biomaterials.2010.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Derkus B.; Okesola B. O.; Barrett D. W.; D’Este M.; Chowdhury T. T.; Eglin D.; Mata A. Multicomponent hydrogels for the formation of vascularized bone-like constructs in vitro. Acta Biomater. 2020, 109, 82–94. 10.1016/j.actbio.2020.03.025. [DOI] [PubMed] [Google Scholar]
- Ghosh M.; Halperin-Sternfeld M.; Grigoriants I.; Lee J.; Nam K. T.; Adler-Abramovich L. Arginine-presenting peptide hydrogels decorated with hydroxyapatite as biomimetic scaffolds for bone regeneration. Biomacromolecules 2017, 18, 3541–3550. 10.1021/acs.biomac.7b00876. [DOI] [PubMed] [Google Scholar]
- Tsutsumi H.; Kawamura M.; Mihara H. Osteoblastic differentiation on hydrogels fabricated from Ca2+-responsive self-assembling peptides functionalized with bioactive peptides. Bioorg. Med. Chem. 2018, 26, 3126–3132. 10.1016/j.bmc.2018.04.039. [DOI] [PubMed] [Google Scholar]
- Zhang R.; Liu Y.; Qi Y.; Zhao Y.; Nie G.; Wang X.; Zheng S. Self-assembled peptide hydrogel scaffolds with VEGF and BMP-2 Enhanced in vitro angiogenesis and osteogenesis. Oral Dis. 2021, in press 10.1111/odi.13785. [DOI] [PubMed] [Google Scholar]
- Misawa H.; Kobayashi N.; Soto-Gutierrez A.; Chen Y.; Yoshida A.; Rivas-Carrillo J. D.; Navarro-Alvarez N.; Tanaka K.; Miki A.; Takei J.; et al. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant. 2006, 15, 903–910. 10.3727/000000006783981369. [DOI] [PubMed] [Google Scholar]
- Ikeno M.; Hibi H.; Kinoshita K.; Hattori H.; Ueda M. Effects of self-assembling peptide hydrogel scaffold on bone regeneration with recombinant human bone morphogenetic protein-2. Int. J. Oral Maxillofac. Implants 2013, 28, e283–9. 10.11607/jomi.te09. [DOI] [PubMed] [Google Scholar]
- He B.; Ou Y.; Chen S.; Zhao W.; Zhou A.; Zhao J.; Li H.; Jiang D.; Zhu Y. Designer bFGF-incorporated d-form self-assembly peptide nanofiber scaffolds to promote bone repair. Mater. Sci. Eng., C 2017, 74, 451–458. 10.1016/j.msec.2016.12.042. [DOI] [PubMed] [Google Scholar]
- Tsukamoto J.; Naruse K.; Nagai Y.; Kan S.; Nakamura N.; Hata M.; Omi M.; Hayashi T.; Kawai T.; Matsubara T. Efficacy of a self-assembling peptide hydrogel, SPG-178-gel, for bone regeneration and three-dimensional osteogenic induction of dental pulp stem cells. Tissue Eng., Part A 2017, 23, 1394–1402. 10.1089/ten.tea.2017.0025. [DOI] [PubMed] [Google Scholar]
- Sun Y.; Li W.; Wu X.; Zhang N.; Zhang Y.; Ouyang S.; Song X.; Fang X.; Seeram R.; Xue W.; He L.; Wu W. Functional Self-Assembling Peptide Nanofiber Hydrogels Designed for Nerve Degeneration. ACS Appl. Mater. Interfaces 2016, 8, 2348–2359. 10.1021/acsami.5b11473. [DOI] [PubMed] [Google Scholar]
- Guo J.; Su H.; Zeng Y.; Liang Y.-X.; Wong W. M.; Ellis-Behnke R. G.; So K.-F.; Wu W. Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine 2007, 3, 311–321. 10.1016/j.nano.2007.09.003. [DOI] [PubMed] [Google Scholar]
- Liu X.; Wang X.; Wang X.; Ren H.; He J.; Qiao L.; Cui F.-Z. Functionalized self-assembling peptide nanofiber hydrogels mimic stem cell niche to control human adipose stem cell behavior in vitro. Acta Biomater. 2013, 9, 6798–6805. 10.1016/j.actbio.2013.01.027. [DOI] [PubMed] [Google Scholar]
- Rauf S.; Susapto H. H.; Kahin K.; Alshehri S.; Abdelrahman S.; Lam J. H.; Asad S.; Jadhav S.; Sundaramurthi D.; Gao X.; Hauser C. A. E. Self-assembling tetrameric peptides allow in situ 3D bioprinting under physiological conditions. J. Mater. Chem. B 2021, 9, 1069–1081. 10.1039/D0TB02424D. [DOI] [PubMed] [Google Scholar]
- Susapto H. H.; Alhattab D.; Abdelrahman S.; Khan Z.; Alshehri S.; Kahin K.; Ge R.; Moretti M.; Emwas A.-H.; Hauser C. A. E. Ultrashort Peptide Bioinks Support Automated Printing of Large-Scale Constructs Assuring Long-Term Survival of Printed Tissue Constructs. Nano Lett. 2021, 21, 2719–2729. 10.1021/acs.nanolett.0c04426. [DOI] [PubMed] [Google Scholar]
- Arthur A.; Zannettino A.; Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 2009, 218, 237–245. 10.1002/jcp.21592. [DOI] [PubMed] [Google Scholar]
- Polo-Corrales L.; Latorre-Esteves M.; Ramirez-Vick J. E. Scaffold design for bone regeneration. J. Nanosci. Nanotechnol. 2014, 14, 15–56. 10.1166/jnn.2014.9127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmes T. C. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol. 2002, 20, 16–21. 10.1016/S0167-7799(01)01840-6. [DOI] [PubMed] [Google Scholar]
- Hauser C. A.; Deng R.; Mishra A.; Loo Y.; Khoe U.; Zhuang F.; Cheong D. W.; Accardo A.; Sullivan M. B.; Riekel C.; Ying J. Y.; Hauser U. A. Natural tri- to hexapeptides self-assemble in water to amyloid beta-type fiber aggregates by unexpected alpha-helical intermediate structures. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1361–1366. 10.1073/pnas.1014796108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lei Y.; Gojgini S.; Lam J.; Segura T. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 2011, 32, 39–47. 10.1016/j.biomaterials.2010.08.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loo Y.; Chan Y. S.; Szczerbinska I.; Tan B. C.; Wan A. C.; Ng H. H.; Hauser C. A. A Chemically Well-Defined, Self-Assembling 3D Substrate for Long-Term Culture of Human Pluripotent Stem Cells. ACS Appl. Bio Mater. 2019, 2, 1406–1412. 10.1021/acsabm.8b00686. [DOI] [PubMed] [Google Scholar]
- Lee J. H.; Jung H. W.; Kang I.-K.; Lee H. B. Cell behaviour on polymer surfaces with different functional groups. Biomaterials 1994, 15, 705–711. 10.1016/0142-9612(94)90169-4. [DOI] [PubMed] [Google Scholar]
- Guo S.; Zhu X.; Li M.; Shi L.; Ong J. L. T.; Jańczewski D.; Neoh K. G. Parallel Control over Surface Charge and Wettability Using Polyelectrolyte Architecture: Effect on Protein Adsorption and Cell Adhesion. ACS Appl. Mater. Interfaces 2016, 8, 30552–30563. 10.1021/acsami.6b09481. [DOI] [PubMed] [Google Scholar]
- Hauser C. A. E.; Zhang S. Designer self-assembling peptide nanofiber biological materials. Chem. Soc. Rev. 2010, 39, 2780–2790. 10.1039/b921448h. [DOI] [PubMed] [Google Scholar]
- Bowerman C. J.; Ryan D. M.; Nissan D. A.; Nilsson B. L. The Effect of Increasing Hydrophobicity on the Self-Assembly of Amphipathic β-Sheet Peptides. Mol. Biosyst. 2009, 5, 1058–1069. 10.1039/b904439f. [DOI] [PubMed] [Google Scholar]
- Susapto H. H.; Alhattab D.; Abdelrahman S.; Khan Z.; Alshehri S.; Kahin K.; Ge R.; Moretti M.; Emwas A. H.; Hauser C. A. E. Ultrashort Peptide Bioinks Support Automated Printing of Large-Scale Constructs Assuring Long-Term Survival of Printed Tissue Constructs. Nano Lett. 2021, 2719. 10.1021/acs.nanolett.0c04426. [DOI] [PubMed] [Google Scholar]
- Friedrichs J.; Taubenberger A.; Franz C. M.; Muller D. J. Cellular Remodelling of Individual Collagen Fibrils Visualized by Time-lapse AFM. J. Mol. Biol. 2007, 372, 594–607. 10.1016/j.jmb.2007.06.078. [DOI] [PubMed] [Google Scholar]
- Nakayama M.; Amano M.; Katsumi A.; Kaneko T.; Kawabata S.; Takefuji M.; Kaibuchi K. Rho-kinase and myosin II activities are required for cell type and environment specific migration. Genes Cells 2005, 10, 107–117. 10.1111/j.1365-2443.2005.00823.x. [DOI] [PubMed] [Google Scholar]
- Beadle C.; Assanah M. C.; Monzo P.; Vallee R.; Rosenfeld S. S.; Canoll P. The Role of Myosin II in Glioma Invasion of the Brain. Mol. Biol. Cell 2008, 19, 3357–3368. 10.1091/mbc.e08-03-0319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedl P.; Wolf K.; Lammerding J. Nuclear mechanics during cell migration. Curr. Opin. Cell Biol. 2011, 23, 55–64. 10.1016/j.ceb.2010.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balzer E. M.; Tong Z.; Paul C. D.; Hung W.-C.; Stroka K. M.; Boggs A. E.; Martin S. S.; Konstantopoulos K. Physical confinement alters tumor cell adhesion and migration phenotypes. FASEB J. 2012, 26, 4045–4056. 10.1096/fj.12-211441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khatau S. B.; Bloom R. J.; Bajpai S.; Razafsky D.; Zang S.; Giri A.; Wu P.-H.; Marchand J.; Celedon A.; Hale C. M.; Sun S. X.; Hodzic D.; Wirtz D. The distinct roles of the nucleus and nucleus-cytoskeleton connections in three-dimensional cell migration. Sci. Rep. 2012, 2, 488 10.1038/srep00488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wen J. H.; Vincent L. G.; Fuhrmann A.; Choi Y. S.; Hribar K. C.; Taylor-Weiner H.; Chen S.; Engler A. J. Interplay of matrix stiffness and protein tethering in stem cell differentiation. Nat. Mater. 2014, 13, 979–987. 10.1038/nmat4051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thievessen I.; Thompson P. M.; Berlemont S.; Plevock K. M.; Plotnikov S. V.; Zemljic-Harpf A.; Ross R. S.; Davidson M. W.; Danuser G.; Campbell S. L.; Waterman C. M. Vinculin–actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth. J. Cell Biol. 2013, 202, 163–177. 10.1083/jcb.201303129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Humphries J. D.; Wang P.; Streuli C.; Geiger B.; Humphries M. J.; Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J. Cell. Biol. 2007, 179, 1043–1057. 10.1083/jcb.200703036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ode A.; Schoon J.; Kurtz A.; Gaetjen M.; Ode J. E.; Geissler S.; Duda G. N. CD73/5′-ecto-nucleotidase acts as a regulatory factor in osteo-/chondrogenic differentiation of mechanically stimulated mesenchymal stromal cells. Eur. Cells Mater. 2013, 25, 37–47. 10.22203/eCM.v025a03. [DOI] [PubMed] [Google Scholar]
- Aslan H.; Zilberman Y.; Kandel L.; Liebergall M.; Oskouian R. J.; Gazit D.; Gazit Z. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006, 24, 1728–1737. 10.1634/stemcells.2005-0546. [DOI] [PubMed] [Google Scholar]
- Huang S.; Ingber D. E. The structural and mechanical complexity of cell-growth control. Nat. Cell Biol. 1999, 1, E131 10.1038/13043. [DOI] [PubMed] [Google Scholar]
- McBeath R.; Pirone D. M.; Nelson C. M.; Bhadriraju K.; Chen C. S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 2004, 6, 483–495. 10.1016/S1534-5807(04)00075-9. [DOI] [PubMed] [Google Scholar]
- Katz B.-Z.; Zamir E.; Bershadsky A.; Kam Z.; Yamada K. M.; Geiger B. Physical state of the extracellular matrix regulates the structure and molecular composition of cell-matrix adhesions. Mol. Biol. Cell 2000, 11, 1047–1060. 10.1091/mbc.11.3.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cukierman E.; Pankov R.; Stevens D. R.; Yamada K. M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294, 1708–1712. 10.1126/science.1064829. [DOI] [PubMed] [Google Scholar]
- Fischbach C.; Kong H. J.; Hsiong S. X.; Evangelista M. B.; Yuen W.; Mooney D. J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 399–404. 10.1073/pnas.0808932106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsiong S. X.; Boontheekul T.; Huebsch N.; Mooney D. J. Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng., Part A 2009, 15, 263–272. 10.1089/ten.tea.2007.0411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park J. S.; Huang N. F.; Kurpinski K. T.; Patel S.; Hsu S.; Li S. Mechanobiology of mesenchymal stem cells and their use in cardiovascular repair. Front. Biosci. 2007, 12, 5098–5116. 10.2741/2551. [DOI] [PubMed] [Google Scholar]
- Tan S.; Fang J. Y.; Yang Z.; Nimni M. E.; Han B. The synergetic effect of hydrogel stiffness and growth factor on osteogenic differentiation. Biomaterials 2014, 35, 5294–5306. 10.1016/j.biomaterials.2014.02.040. [DOI] [PubMed] [Google Scholar]
- Knight B.; Laukaitis C.; Akhtar N.; Hotchin N. A.; Edlund M.; Horwitz A. R. Visualizing muscle cell migration in situ. Curr. Biol. 2000, 10, 576–585. 10.1016/S0960-9822(00)00486-3. [DOI] [PubMed] [Google Scholar]
- Roskelley C.; Desprez P.; Bissell M. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12378–12382. 10.1073/pnas.91.26.12378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thievessen I.; Fakhri N.; Steinwachs J.; Kraus V.; McIsaac R. S.; Gao L.; Chen B.-C.; Baird M. A.; Davidson M. W.; Betzig E.; et al. Vinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen. FASEB J. 2015, 29, 4555–4567. 10.1096/fj.14-268235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Case L. B.; Baird M. A.; Shtengel G.; Campbell S. L.; Hess H. F.; Davidson M. W.; Waterman C. M. Molecular mechanism of vinculin activation and nanoscale spatial organization in focal adhesions. Nat. Cell Biol. 2015, 17, 880–892. 10.1038/ncb3180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carisey A.; Ballestrem C. Vinculin, an adapter protein in control of cell adhesion signalling. Eur. J. Cell Biol. 2011, 90, 157–163. 10.1016/j.ejcb.2010.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu W.; Baribault H.; Adamson E. D. Vinculin knockout results in heart and brain defects during embryonic development. Development 1998, 125, 327–337. [DOI] [PubMed] [Google Scholar]
- Kumar G.; Tison C. K.; Chatterjee K.; Pine P. S.; McDaniel J. H.; Salit M. L.; Young M. F.; Simon C. G. Jr. The determination of stem cell fate by 3D scaffold structures through the control of cell shape. Biomaterials 2011, 32, 9188–9196. 10.1016/j.biomaterials.2011.08.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pablo Rodríguez J.; González M.; Ríos S.; Cambiazo V. Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation. J. Cell. Biochem. 2004, 93, 721–731. 10.1002/jcb.20234. [DOI] [PubMed] [Google Scholar]
- Treiser M. D.; Yang E. H.; Gordonov S.; Cohen D. M.; Androulakis I. P.; Kohn J.; Chen C. S.; Moghe P. V. Cytoskeleton-based forecasting of stem cell lineage fates. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 610–615. 10.1073/pnas.0909597107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hunter G. K.; Hauschka P. V.; Poole R. A.; Rosenberg L. C.; Goldberg H. A. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 1996, 317, 59–64. 10.1042/bj3170059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang J.; Cui X.; Zhou Y.; Xiang Q. Core-shell PLGA/collagen nanofibers loaded with recombinant FN/CDHs as bone tissue engineering scaffolds. Connect. Tissue Res. 2014, 55, 292–298. 10.3109/03008207.2014.918112. [DOI] [PubMed] [Google Scholar]
- Khan S. N.; Lane J. M.. Bone Tissue Engineering: Basic Science and Clinical Concepts. Orthopedic Tissue Engineering; CRC Press, 2004; pp 177–194. [Google Scholar]
- Oreffo R. O.; Kusec V.; Romberg S.; Triffitt J. T. Human bone marrow osteoprogenitors express estrogen receptor-alpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation. J. Cell. Biochem. 1999, 75, 382–392. . [DOI] [PubMed] [Google Scholar]
- Frank O.; Heim M.; Jakob M.; Barbero A.; Schäfer D.; Bendik I.; Dick W.; Heberer M.; Martin I. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 2002, 85, 737–746. 10.1002/jcb.10174. [DOI] [PubMed] [Google Scholar]
- Miron R.; Zhang Y. Osteoinduction: a review of old concepts with new standards. J. Dent. Res. 2012, 91, 736–744. 10.1177/0022034511435260. [DOI] [PubMed] [Google Scholar]
- Rittling S. R.; Matsumoto H. N.; Mckee M. D.; Nanci A.; An X. R.; Novick K. E.; Kowalski A. J.; Noda M.; Denhardt D. T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 1998, 13, 1101–1111. 10.1359/jbmr.1998.13.7.1101. [DOI] [PubMed] [Google Scholar]
- Chellaiah M. A.; Kizer N.; Biswas R.; Alvarez U.; Strauss-Schoenberger J.; Rifas L.; Rittling S. R.; Denhardt D. T.; Hruska K. A. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell 2003, 14, 173–189. 10.1091/mbc.e02-06-0354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bax D. V.; Rodgers U. R.; Bilek M. M.; Weiss A. S. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin αVβ3. J. Biol. Chem. 2009, 284, 28616–28623. 10.1074/jbc.M109.017525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taddese S.; Weiss A. S.; Jahreis G.; Neubert R. H.; Schmelzer C. E. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biol. 2009, 28, 84–91. 10.1016/j.matbio.2008.12.002. [DOI] [PubMed] [Google Scholar]
- Getie M.; Schmelzer C.; Neubert R. Characterization of peptides resulting from digestion of human skin elastin with elastase. Proteins 2005, 61, 649–657. 10.1002/prot.20643. [DOI] [PubMed] [Google Scholar]
- Phillips J. E.; Petrie T. A.; Creighton F. P.; García A. J. Human mesenchymal stem cell differentiation on self-assembled monolayers presenting different surface chemistries. Acta Biomater. 2010, 6, 12–20. 10.1016/j.actbio.2009.07.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nemir S.; West J. L. Synthetic materials in the study of cell response to substrate rigidity. Ann. Biomed. Eng. 2010, 38, 2–20. 10.1007/s10439-009-9811-1. [DOI] [PubMed] [Google Scholar]
- Holst J.; Watson S.; Lord M. S.; Eamegdool S. S.; Bax D. V.; Nivison-Smith L. B.; Kondyurin A.; Ma L.; Oberhauser A. F.; Weiss A. S.; Rasko J. E. J. Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat. Biotechnol. 2010, 28, 1123. 10.1038/nbt.1687. [DOI] [PubMed] [Google Scholar]
- Rowlands A. S.; George P. A.; Cooper-White J. J. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am. J. Physiol.: Cell Physiol. 2008, 295, C1037–C1044. 10.1152/ajpcell.67.2008. [DOI] [PubMed] [Google Scholar]
- Saha K.; Keung A. J.; Irwin E. F.; Li Y.; Little L.; Schaffer D. V.; Healy K. E. Substrate modulus directs neural stem cell behavior. Biophys. J. 2008, 95, 4426–4438. 10.1529/biophysj.108.132217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huebsch N.; Arany P. R.; Mao A. S.; Shvartsman D.; Ali O. A.; Bencherif S. A.; Rivera-Feliciano J.; Mooney D. J. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat. Mater. 2010, 9, 518. 10.1038/nmat2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kabiri K.; Omidian H.; Hashemi S.; Zohuriaan-Mehr M. Synthesis of fast-swelling superabsorbent hydrogels: effect of crosslinker type and concentration on porosity and absorption rate. Eur. Polym. J. 2003, 39, 1341–1348. 10.1016/S0014-3057(02)00391-9. [DOI] [Google Scholar]
- Hale B. W.; Goodrich L. R.; Frisbie D. D.; McIlwraith C. W.; Kisiday J. D. Effect of scaffold dilution on migration of mesenchymal stem cells from fibrin hydrogels. Am. J. Vet. Res. 2012, 73, 313–318. 10.2460/ajvr.73.2.313. [DOI] [PubMed] [Google Scholar]
- Cuchiara M. P.; Allen A. C.; Chen T. M.; Miller J. S.; West J. L. Multilayer microfluidic PEGDA hydrogels. Biomaterials 2010, 31, 5491–5497. 10.1016/j.biomaterials.2010.03.031. [DOI] [PubMed] [Google Scholar]
- Cheng R.; Yan Y.; Liu H.; Chen H.; Pan G.; Deng L.; Cui W. Mechanically enhanced lipo-hydrogel with controlled release of multi-type drugs for bone regeneration. Appl. Mater. Today 2018, 12, 294–308. 10.1016/j.apmt.2018.06.008. [DOI] [Google Scholar]
- Engler A. J.; Sen S.; Sweeney H. L.; Discher D. E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126, 677–689. 10.1016/j.cell.2006.06.044. [DOI] [PubMed] [Google Scholar]
- Sivaraj K. K.; Adams R. H. Blood vessel formation and function in bone. Development 2016, 143, 2706–2715. 10.1242/dev.136861. [DOI] [PubMed] [Google Scholar]
- Kim S.; Cha C. Enhanced mechanical and electrical properties of heteroscaled hydrogels infused with aqueous-dispersible hybrid nanofibers. Biofabrication 2020, 12, 015020 10.1088/1758-5090/ab5385. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.